Description

Potassium 7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate is a high-purity potassium salt derivative of a benzodiazepine carboxylic acid, serving as a critical pharmaceutical intermediate. Its primary value lies in enabling the synthesis of active pharmaceutical ingredients (APIs) with precise chemical and stereochemical control. This compound is essential for manufacturers in the pharmaceutical and fine chemical sectors, particularly those developing or producing central nervous system (CNS) therapeutics and other specialized medicinal agents.

Application

• Key Intermediate in API Synthesis: Serves as a crucial building block for the production of benzodiazepine-class active pharmaceutical ingredients.
• Pharmaceutical Research & Development: Used in medicinal chemistry for the discovery and optimization of new therapeutic candidates targeting neurological pathways.
• Generic Drug Manufacturing: Employed in the cost-effective and reliable production of generic versions of established benzodiazepine medications.
• Fine Chemical Production: Acts as a specialized intermediate for synthesizing complex molecules requiring the benzodiazepine core structure.
• Reference Standard: Utilized as an analytical standard in quality control laboratories for method development and impurity profiling.

Basic Information

Product Name	Potassium 7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate
CAS No.	5991-71-9
Molecular Formula	C16H10ClKN2O3
Molecular Weight	352.82 g/mol
Synonyms	Potassium 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine-2-one-3-carboxylate; Potassium 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-one-3-carboxylate; 3-Carboxy-7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one Potassium Salt; 7-Chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-one-3-carboxylic Acid Potassium Salt; Potassium Cloxazolam Carboxylate; Potassium Salt of Cloxazolam Acid
EINECS	Contact for details

Quality Control

Our Potassium 7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical intermediate applications. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 2.0%
Residue on Ignition (Sulfated Ash)	Conforms
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.